Table 1.
Patient and disease characteristics in 22,936 patients with new diagnosed urinary bladder cancer between 2005 and 2014
| n | % | |
|---|---|---|
| Gender | ||
| Male | 17,182 | 74.9 |
| Female | 5754 | 25.1 |
|
| ||
| Age at diagnosis | ||
| Mean (median, Q1–Q3) | 72.9 (74.0, 66–81) years | |
|
| ||
| T stage | ||
| Ta | 11,198 | 48.8 |
| Tis | 606 | 2.6 |
| T1 | 512 | 22.3 |
| T2–T4 | 5508 | 24.0 |
| T0/TX* | 503 | 2.2 |
|
| ||
| N stage | ||
| N0/NX* | 22,195 | 96.8 |
| N1–N3 | 741 | 3.2 |
|
| ||
| M stage | ||
| M0 | 22,189 | 96.7 |
| M1 | 747 | 3.3 |
|
| ||
| Tumor grade | ||
| G1/LMP | 6079 | 26.5 |
| G2 | 6845 | 29.8 |
| G3/G4 | 9008 | 39.2 |
| GX* | 1004 | 4.3 |
|
| ||
| TNM and G grouping | ||
| TaG1–2 | 10,009 | 43.6 |
| TaG3 | 1096 | 4.8 |
| TIS | 604 | 2.6 |
| T1 | 5011 | 21.8 |
| T2–T4N0M0 | 4501 | 19.6 |
| N+ and/or M+ | 1210 | 5.3 |
*
Includes missing values.